---
$id: https://graph.org.ai/products/commodity/51271609
$type: Product
source: UNSPSC
code: "51271609"
title: "Clodacaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clodacaine

**UNSPSC Code**: 51271609
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H743H7R6YE. European Medicines Agency schedules Clodacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06688MIG. Clodacaine generally arises in the molecular formula C16H26CLN3O. The term CLODACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, list 5.) CLODACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clodacaine under HS 29242995 and SITC 51479. As of Q4 2014, CLODACAINE remains the US FDA Preferred Term for this commodity. Clodacaine bears US NLM identifiers UMLS ID C2699358 and NCI Concept Code C77322. SMILES: CLC1C(NC(=O)CN(CCN(CC)CC)CC)CCCC1.

